(In English) [DOI] [PubMed] [Google Scholar] 36.Kindel T.L., Wang A.Y., Wadhwa A., Schulman A.R., Sharaiha R.Z., Kroh M., Ghanem O.M., Levy S., Joshi G.P., LaMasters T., et al
What does the Precision Peptide Genetic Test reveal about my weight-loss medication response
[2] [3] These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)with tirzepatide being a dual GIP/GLP-1 receptor agonist rather than a pure GLP-1 agonist
No studies have addressed whether dulaglutide could cross the BBB
TB-500 (Thymosin -4) demonstrated +72% capillary density in cardiac ischemia models (Bock-Marquette, Nature 2004)
In a study conducted by Luna-Marco et al